Table 1.

Effects of TT and 9CTT on the Proliferation and Differentiation of Human Myeloid Leukemia Cells

Cell Treatment Growth (% of control) Cell Cycle (%) Morphological Differentiation-150 (%) CD11b (mean intensity)
G1G2/M S
NB4  None  100  38 ± 2 13 ± 1  49 ± 1  1 ± 0  1.7 ± 0.0 
 TT  85 ± 8  36 ± 1  16 ± 1  48 ± 1 2 ± 1  3.8 ± 0.0  
 9CTT  44 ± 5 58 ± 2  11 ± 1  30 ± 1  49 ± 8 4.5 ± 0.2  
HT93  None  100  41 ± 2 10 ± 1  49 ± 1  0 ± 0  1.7 ± 0.0 
 TT  103 ± 3  61 ± 2  8 ± 1  31 ± 1 3 ± 1  3.1 ± 0.1  
 9CTT  36 ± 2 72 ± 1  10 ± 0  18 ± 1  54 ± 1 4.3 ± 0.1  
U937  None  100    0 ± 0  1.4 ± 0.0  
 TT  72 ± 3 ND  18 ± 3  1.8 ± 0.0 
 9CTT  41 ± 1     30 ± 3 2.1 ± 0.1  
HL-60  None  100    0 ± 0  2.9 ± 0.3  
 TT  64 ± 4 ND  2 ± 1  1.8 ± 0.1  
 9CTT 58 ± 6     6 ± 0  1.9 ± 0.0 
Cell Treatment Growth (% of control) Cell Cycle (%) Morphological Differentiation-150 (%) CD11b (mean intensity)
G1G2/M S
NB4  None  100  38 ± 2 13 ± 1  49 ± 1  1 ± 0  1.7 ± 0.0 
 TT  85 ± 8  36 ± 1  16 ± 1  48 ± 1 2 ± 1  3.8 ± 0.0  
 9CTT  44 ± 5 58 ± 2  11 ± 1  30 ± 1  49 ± 8 4.5 ± 0.2  
HT93  None  100  41 ± 2 10 ± 1  49 ± 1  0 ± 0  1.7 ± 0.0 
 TT  103 ± 3  61 ± 2  8 ± 1  31 ± 1 3 ± 1  3.1 ± 0.1  
 9CTT  36 ± 2 72 ± 1  10 ± 0  18 ± 1  54 ± 1 4.3 ± 0.1  
U937  None  100    0 ± 0  1.4 ± 0.0  
 TT  72 ± 3 ND  18 ± 3  1.8 ± 0.0 
 9CTT  41 ± 1     30 ± 3 2.1 ± 0.1  
HL-60  None  100    0 ± 0  2.9 ± 0.3  
 TT  64 ± 4 ND  2 ± 1  1.8 ± 0.1  
 9CTT 58 ± 6     6 ± 0  1.9 ± 0.0 

Cells (5 × 104 cells were incubated with or without 1.5 ×  10−5 mol/L TT or 9CTT for 4 days. Values represent the means ± SD of three separate experiments.

Abbreviation: ND, not done.

F0-150

Cells differentiating into myelocytes and more mature cells were counted.

Close Modal

or Create an Account

Close Modal
Close Modal